financetom
Business
financetom
/
Business
/
Darling Ingredients Q4 Earnings Fall, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Darling Ingredients Q4 Earnings Fall, Revenue Rises
Mar 11, 2026 3:47 AM

05:12 PM EST, 02/11/2026 (MT Newswires) -- Darling Ingredients ( DAR ) reported Q4 earnings late Wednesday of $0.35 per diluted share, down from $0.63 a year earlier.

Analysts surveyed by FactSet expected $0.40.

Revenue for the quarter ended Jan. 3 was $1.71 billion, up from $1.42 billion a year earlier.

Analysts surveyed by FactSet expected $1.53 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Arrowhead Pharmaceuticals Shares Rise After Novartis Licensing Deal Announced
Update: Arrowhead Pharmaceuticals Shares Rise After Novartis Licensing Deal Announced
Sep 2, 2025
11:25 AM EDT, 09/02/2025 (MT Newswires) -- (Updates to include Arrowhead's stock movement in the headline and the first paragraph.) Arrowhead Pharmaceuticals ( ARWR ) shares rose 9.2% in recent Tuesday trading after the company announced a global licensing and collaboration agreement for its ARO-SNCA preclinical stage siRNA therapy to treat synucleinopathies, including Parkinson's disease, with Novartis ( NVS )...
Nukkleus Stock Soars To Fresh Highs On Tiltan Defense Tech Deal
Nukkleus Stock Soars To Fresh Highs On Tiltan Defense Tech Deal
Sep 2, 2025
Nukkleus Inc. ( NUKK ) shares soared on Tuesday after the company said it will acquire Israel-based Tiltan Software Engineering Ltd. in a $14 million deal. The acquisition, to be paid in a mix of cash and stock, is expected to close following regulatory approval and audited financials. The announcement underscores growing demand for AI-powered simulation and GPS-denied navigation tools...
Blue Bird Insider Sold Shares Worth $767,260, According to a Recent SEC Filing
Blue Bird Insider Sold Shares Worth $767,260, According to a Recent SEC Filing
Sep 2, 2025
11:25 AM EDT, 09/02/2025 (MT Newswires) -- Phil Horlock, Director, on August 28, 2025, sold 13,000 shares in Blue Bird ( BLBD ) for $767,260. Following the Form 4 filing with the SEC, Horlock has control over a total of 240,766 common shares of the company, with 240,766 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1589526/000157947725000018/xslF345X05/wk-form4_1756826178.xml Price: 57.75, Change: -0.64, Percent Change:...
Update: Ionis Pharma Shares Rise After Reporting 'Positive' Olezarsen Data in Severe Hypertriglyceridemia
Update: Ionis Pharma Shares Rise After Reporting 'Positive' Olezarsen Data in Severe Hypertriglyceridemia
Sep 2, 2025
11:26 AM EDT, 09/02/2025 (MT Newswires) -- (Updates with recent stock movement in the headline and first paragraph.) Ionis Pharmaceuticals ( IONS ) shares were up more than 33% in recent Tuesday trading after the company reported topline data from phase 3 studies of olezarsen, which showed that the drug candidate significantly reduced fasting triglycerides and acute pancreatitis events in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved